Koninklijke Philips Nv (PHG) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Koninklijke Philips Nv  (NYSE: PHG)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Koninklijke Philips Nv's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Koninklijke Philips Nv's ROI in the fourth quarter of 2025?
Koninklijke Philips Nv achieved a return on average invested assets (ROI) of 4.62 % in its fourth quarter of 2025, this is above PHG's average return on investment of 2.31%.
Koninklijke Philips Nvs investments during the 12 months ending in the fourth quarter of 2025 are valued at $21 billion

ROI has improved compared to -3.63% in the third quarter of 2025, due to net income growth.

Within the Healthcare sector 203 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from to 3301.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Investment Change TTM -1.15 % 5.76 % 17.42 % 31.74 % 49.71 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 22,208 21,614 21,614 21,614 21,243
Return On Investment (TTM) 4.62 % -3.63 % -3.6 % -3.58 % -3.55 %
PHG's Overall Ranking # 3301 # # # # 3386
Seq. Investment Change TTM 1.12 % -0.76 % -0.75 % -0.75 % 8.19 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 1,005 -782 -782 -782 -782

PHG Company Profile >> Back to PHG Roi Comparisons >> See Annual PHG Return On Investment



Return On Investment PHG's Ranking
Within: No.
Industry # 12
Sector # 204
Overall # 3301

Return On Investment Statistics
High Average Low
12.1 %
2.31 %
-8.49 %
(Dec 31 2021)   (Dec 31 2022)







Financial Statements
Koninklijke Philips Nv's IV. Quarter Investments $ 22,208 Millions PHG's Balance sheet
Koninklijke Philips Nv's IV. Quarter Income $ 1,005 Millions Quarterly PHG's Income Statement
PHG's Income by Division See PHG's Income by Division


PHG Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 22,208 21,243 14,580 15,536 26,481
Y / Y Investment Growth 4.54 % 45.7 % -6.16 % -41.33 % 6.95 %
Net Income in Millions 1,014 -755 -501 -1,691 3,931
Y / Y Net Income Growth - - - - 188.31 %
Annual Return On Investment 4.57 % -3.56 % -3.43 % -10.88 % 14.85 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 4.57 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PHG's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PHG's Competitors
Subscribers only: Roi for Koninklijke Philips Nv's Suppliers
Subscribers only: Return On Investment for PHG's Customers

Other Ratios
PHG's Roa PHG's Inventory Turnover Ratio PHG's Growth Rates PHG's Dividend Statistics
PHG's Profitability Ratios PHG's Asset Turnover Ratio PHG's Dividend Growth
PHG's Roe PHG's Valuation Ratios PHG's Financial Strength Ratios PHG's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector ROI
Regeneron Pharmaceuticals Inc   12.63 %
Novartis Ag  12.62 %
Universal Health Services Inc   12.38 %
Lantheus Holdings Inc   12.33 %
Prestige Consumer Healthcare Inc   12.12 %
Msa Safety Inc  12.06 %
Amgen Inc   11.95 %
Encompass Health Corporation  11.94 %
Solventum Corporation  11.89 %
Ufp Technologies Inc   11.88 %
Alpha Pro Tech Ltd   11.70 %
Globus Medical Inc   11.70 %
Nrc Health  11.33 %
Nephros Inc   11.27 %
3m Company  11.03 %
Pacific Health Care Organization Inc  10.98 %
Nature s Sunshine Products inc   10.95 %
Progyny Inc   10.84 %
Escalon Medical Corp   10.78 %
Qiagen N v   10.69 %
Cryoport inc   10.68 %
Siga Technologies Inc  10.57 %
Ligand Pharmaceuticals Incorporated  10.56 %
Healthcare Services Group Inc   10.55 %
Genmab A  10.37 %
Bristol myers Squibb Company  10.36 %
Brainsway Ltd   10.35 %
Kiniksa Pharmaceuticals International Plc  10.32 %
Penumbra Inc  10.30 %
Cypherpunk Technologies Inc   10.27 %

Date modified: 2026-06-22T16:58:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.